NIH-funded research R01 grant

NAFLD in PCOS: Do androgens drive liver injury and fatty liver progression?

Official title: Nonalcoholic Fatty Liver Disease (NAFLD) in Polycystic Ovary Syndrome: The Role of Androgens on Liver Injury and NAFLD Progression

Funded at University of California, San Francisco · NIH-11345167 · Data updated 2026-11-12

Young women with PCOS may face liver disease progression due to high androgen levels, and this research looks at targeted ways to slow or prevent that progression.

More Fatty Liver research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of California, San Francisco
NIH-funded
Lab location1 site (San Francisco, United States)
Project startSeptember 1, 2023
Project endJune 30, 2028
Funding year2026
Award (this year)$689,625
NIH project number5R01DK134633-04
Project IDNIH-11345167 on NIH RePORTER

Who could benefit from this research

Could help

Adults with PCOS and signs of liver involvement or NAFLD/NASH, especially women of reproductive age.

Less likely to help

Patients without PCOS or without liver involvement may not directly benefit from this research.

What this research studies

If you have PCOS and are dealing with liver concerns, this project explores whether androgens worsen liver injury and fat buildup in the liver. The study focuses on how androgens might affect fat tissue and liver metabolism, aiming to identify specific targets for therapy. By examining hormone-related pathways in PCOS patients, researchers hope to uncover why liver disease starts earlier and progresses faster in this group. Findings could point to new treatments that block harmful androgen effects on the liver.

Why it matters

Potential benefit: If successful, this work could lead to new hormone-targeted therapies to prevent or slow liver disease in women with PCOS.

How similar studies have gone: Previous data suggest a link between androgens and liver disease in PCOS, but this project seeks mechanistic targets that are not yet proven in humans.

Where this research is happening

  • University of California, San Francisco
    San Francisco, United States
    Active

Researchers

  • Principal investigator: Sarkar, Monika — University of California, San Francisco
  • Study coordinator: Sarkar, Monika

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.